Sanofi Consumer Healthcare India Limited reported strong financial performance for the first quarter of FY26, with revenue growing 33% year-on-year, driven by sustained momentum across key business segments.

Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market, while exports also contributed meaningfully to overall growth. 

Profit after tax (PAT) for the quarter stood at ₹678 million, marking a 36% year-on-year increase.

Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, said, “Our performance this quarter reflects consistent, disciplined execution across our key markets. Domestic business outpaced the market, delivering both market share gains and volume growth."

"The exports made a meaningful contribution to overall results. Guided by science and driven by purpose, we remain committed to simplifying self-care and making it more accessible and effective for consumers,” Bakshi added further.